Mercer Global Advisors’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-41,471
Closed -$975K 1167
2019
Q4
$975K Buy
41,471
+2,156
+5% +$50.7K 0.02% 534
2019
Q3
$727K Buy
39,315
+2,563
+7% +$47.4K 0.02% 576
2019
Q2
$683K Sell
36,752
-1,800
-5% -$33.5K 0.02% 573
2019
Q1
$942K Buy
+38,552
New +$942K 0.03% 429